NCT04290494

Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007-2017: Analysis of China National Stroke Registry (CNSR) I, II, and III; CTP-Draft Review Performed;

Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007 2017: Analysis of China National Stroke Registry (CNSR) I, II, and III

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 42,188 (actual)
• Sponsor: Boehringer Ingelheim · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The present study is to be conducted based on the AIS patient data collected from CNSR I, II, and III. The primary objectives are: * To investigate the temporal changes in the proportion of intravenous recombinant plasminogen activator (IV rtPA) treatment from 2007 to 2017 among Intravenous Thrombolytics (IVT) eligible patients (patient groups B and B') and overall AIS patients (patient group A) in China; * To investigate the temporal changes in IV rtPA treatment time intervals from 2007 to 2017 among IV rtPA treated patients (patient groups C and C') in China. The secondary objectives are: \- To describe the demographic and clinical characteristics of the IV rtPA treated patients (patient groups C and C'), IVT eligible patients (patient groups B and B') and the overall AIS patients (patient group A) from 2007 to 2017 from the CNSR I to III.

Conditions

• Stroke

Interventions

Type	Name	Description
DRUG	IV rtPA (intravenous recombinant plasminogen activator)	intravenous injection

Timeline

• Start date: 2020-09-21
• Primary completion: 2020-09-30
• Completion: 2020-09-30
• First posted: 2020-03-02
• Last updated: 2021-11-05
• Results posted: 2021-11-05

Locations

1 site across 1 country: China